// App-Quantinova.ai

: A retrospective review of the benefits vs. safety implications of prednisolone during docetaxel chemotherapy alongside androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC).

Researchers

Presenter

  • Molly Jameson

Principal Investigators

  • Claire Barker

  • Jennifer King

  • Hui-Wen Liang

  • Charles Carey

  • Nicole Cripps

  • Daisy Jameson

  • Kamlesh Patel

  • Andrew Robinson

  • Andrew Hudson

  • Yee Pei Song

  • Ruth Conroy

  • Maria Serra

  • Ananya Choudhury

  • John Logue

  • James Wylie

  • Anna Tran

Medical Centers

  • Queen Mary University of London, London, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Prednisolone

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved